Founded in 2001, Future Science Group’s portfolio consists of two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, Future Science Group develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Pharmacogenomics and the award-winning Regenerative Medicine.

The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.

Learn more about Future Science Group at www.future-science-group.com

R&P License - Future Science Group
2:01
R&P License - Future Science Group
Sargramostim and ICIs: combinatorial therapeutic studies in metastatic melanoma – video abstract
6:33
Sargramostim and ICIs: combinatorial therapeutic studies in metastatic melanoma – video abstract
Novel hydrophilic-phase extraction, HILIC & HRMS quantification of an RNA oligonucleotide in plasma
1:55
Novel hydrophilic-phase extraction, HILIC & HRMS quantification of an RNA oligonucleotide in plasma
Spanish version: Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease
7:09
Spanish version: Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease
Plain language summaries from Future Science Group
2:04
Plain language summaries from Future Science Group
Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease
7:09
Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease
FON-2020-0823 - Video abstract
3:32
FON-2020-0823 - Video abstract
Final analysis of the GioTag study
6:26
Final analysis of the GioTag study
FSG Future Star Award 2019
0:45
FSG Future Star Award 2019
Sequential afatinib and osimertinib in EGFR mutation-positive NSCLC patients: updated results
6:43
Sequential afatinib and osimertinib in EGFR mutation-positive NSCLC patients: updated results
What is a “Baseline Risk Adjustment”?
2:54
What is a “Baseline Risk Adjustment”?
FSFS Award 2019 Finalist Announced
0:46
FSFS Award 2019 Finalist Announced
Three-dimensional 3D Gabriel’s biplot visualization
0:21
Three-dimensional 3D Gabriel’s biplot visualization
HTX-019 via 2-min Injection or 30-min Infusion in Healthy Subjects
3:55
HTX-019 via 2-min Injection or 30-min Infusion in Healthy Subjects
Invstigating Mal de Debarquement Syndrome
51:15
Invstigating Mal de Debarquement Syndrome
INSIGHT MM – the largest real-world study of patients with multiple myeloma
5:28
INSIGHT MM – the largest real-world study of patients with multiple myeloma
Bioelectronics in Medicine Discount
0:19
Bioelectronics in Medicine Discount
Talimogene Laherparepvec (T-VEC): Intrahepatic Injection Procedures
10:48
Talimogene Laherparepvec (T-VEC): Intrahepatic Injection Procedures
Network Meta-Analysis of 1L Treatments for NSCLC
4:57
Network Meta-Analysis of 1L Treatments for NSCLC
International Women’s Day 2019
0:30
International Women’s Day 2019
Tumor clonality in EGFR mutation-positive NSCLC
10:30
Tumor clonality in EGFR mutation-positive NSCLC
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive NSCLC
6:28
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive NSCLC
Meet the 2018 FS Early Career Research Award winner Viviana Mucci
4:47
Meet the 2018 FS Early Career Research Award winner Viviana Mucci
Tristan Free on our open access oncology journal collection
1:21
Tristan Free on our open access oncology journal collection
Metastatic Colorectal Cancer Markers to inform treatment selection
6:25
Metastatic Colorectal Cancer Markers to inform treatment selection
Tumor Location Prognostic or Predictive Marker in Metastatic Colorectal Cancer
6:14
Tumor Location Prognostic or Predictive Marker in Metastatic Colorectal Cancer
The rationale for combination therapy in patients with aggressive B-cell non-Hodgkin lymphoma
2:36
The rationale for combination therapy in patients with aggressive B-cell non-Hodgkin lymphoma
Video abstract: Functional foods and cancer on Pinterest and PubMed: Myths and science
1:28
Video abstract: Functional foods and cancer on Pinterest and PubMed: Myths and science
Time-lapse video of 2GF-GNP uptake by live cells
2:59
Time-lapse video of 2GF-GNP uptake by live cells
Time-lapse video of 2GF-GNP uptake by live cells, before processing
3:00
Time-lapse video of 2GF-GNP uptake by live cells, before processing